JNJ-90301900: JNJ-90301900 will be injected intratumorally and/or intranodally.
Durvalumab: Durvalumab will be administered as intravenous (IV) infusion as cIT.
Concurrent Chemo/Radiation Therapy (cCRT): Radiation by intensity modulated radiation therapy (IMRT) will be administered.
Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin: Carboplatin will be administered as IV infusion as platinum-based doublet chemotherapy.
Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel: Paclitaxel will be administered as IV infusion as platinum-based doublet chemotherapy.
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose best response is complete response or partial response during the study) in participants with locally advanced and unresectable stage III non-small cell lung cancer.
| Facility | City | Region | Status |
|---|---|---|---|
| Moores Cancer Center at UC San Diego Health | La Jolla | California | Recruiting |
| University of Connecticut Health Center | Farmington | Connecticut | Recruiting |
| Yale University | New Haven | Connecticut | Recruiting |
| University of Miami | Miami | Florida | Recruiting |
| Orlando Health Cancer Institute | Orlando | Florida | Recruiting |
| Emory University Winship Cancer Institute | Atlanta | Georgia | Recruiting |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | Recruiting |
| Washington University in St Louis | St Louis | Missouri | Recruiting |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | Recruiting |
| NYU Langone Health | New York | New York | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York | New York | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | Recruiting |
| FirstHealth of the Carolinas | Pinehurst | North Carolina | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | Recruiting |
| Oregon Health And Science University | Portland | Oregon | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | Recruiting |
| University of Vermont Medical Center | Burlington | Vermont | Recruiting |
| Royal Brisbane and Women's Hospital | Herston | Australia | Recruiting |
| Sir Charles Gairdner Hospital | Nedlands | Australia | Recruiting |
| Macquarie University | North Ryde | Australia | Recruiting |
| Royal Melbourne Hospital | Parkville | Australia | Recruiting |
| Fundacao Pio XII | Barretos | Brazil | Recruiting |
| Sociedade Beneficente de Senhoras Hospital Sirio Libanes | São Paulo | Brazil | Recruiting |
| Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein | São Paulo | Brazil | Recruiting |
| Dongguan People s Hospital | Dongguan | China | Recruiting |
| The First Affiliated Hospital Sun Yat sen University | Guangzhou | China | Recruiting |
| The Affiliated Cancer Hospital of Shandong First Medical University | Jinan | China | Recruiting |
| Hopital De La Cavale Blanche | Brest | France | Recruiting |
| Hopital Nord Marseille | Marseille | France | Recruiting |
| Hopital Tenon | Paris | France | Recruiting |
| Institut Curie | Paris | France | Recruiting |
| Gustave Roussy | Villejuif | France | Recruiting |
| Prince of Wales Hospital | Shatin | Hong Kong | Recruiting |
| Antoni van Leeuwenhoek | Amsterdam | Netherlands | Recruiting |
| Radboud Umcn | Nijmegen | Netherlands | Recruiting |
| Hosp. Univ. 12 de Octubre | Madrid | Spain | Recruiting |
| Clinica Univ. de Navarra | Pamplona | Spain | Recruiting |
| Hosp. Clinico Univ. de Santiago | Santiago de Compostela | Spain | Recruiting |
| Hosp. Univ. I Politecni La Fe | Valencia | Spain | Recruiting |
+ 3 more sites — see the full list on the official registry below.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06667908 on ClinicalTrials.gov ↗ ← All trials in the USA